|
1
|
Jin J: Screening for osteoporosis to
prevent fractures. JAMA. 333:5472025. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Reid IR and Billington EO: Drug therapy
for osteoporosis in older adults. Lancet. 399:1080–1092. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang B, He W, Pei Z, Guo Q, Wang J, Sun
M, Yang X, Ariben J, Li S, Feng W, et al: Plasma proteins,
circulating metabolites mediate causal inference studies on the
effect of gut bacteria on the risk of osteoporosis development.
Ageing Res Rev. 101:1024792024. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yin JQ, Zhu J and Ankrum JA: Manufacturing
of primed mesenchymal stromal cells for therapy. Nat Biomed Eng.
3:90–104. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Dalle Carbonare L, Cominacini M, Trabetti
E, Bombieri C, Pessoa J, Romanelli MG and Valenti MT: The bone
microenvironment: New insights into the role of stem cells and cell
communication in bone regeneration. Stem Cell Res Ther. 16:1692025.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang L, Yuan X, Song R, Yuan Z, Zhao Y
and Zhang Y: Engineered 3D mesenchymal stem cell aggregates with
multifunctional prowess for bone regeneration: Current status and
future prospects. J Adv Res. Apr 11–2025.doi:
10.1016/j.jare.2025.04.008 (Epub ahead of print).
|
|
7
|
Wu KC, Chang YH, Ding DC and Lin SZ:
Mesenchymal stromal cells for aging cartilage regeneration: A
review. Int J Mol Sci. 25:129112024. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Artamonov MY and Sokov EL: Intraosseous
delivery of mesenchymal stem cells for the treatment of bone and
hematological diseases. Curr Issues Mol Biol. 46:12672–12693. 2024.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Ban JY, Park HJ, Kim SK, Kim JW, Lee YA,
Choi IA, Chung JH and Hong SJ: Association of forkhead box J3
(FOXJ3) polymorphisms with rheumatoid arthritis. Mol Med Rep.
8:1235–1241. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Ni L, Xie H and Tan L: Multiple roles of
FOXJ3 in spermatogenesis: A lesson from Foxj3 conditional knockout
mouse models. Mol Reprod Deve. 83:1060–1069. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin J, Zhou S, Li C, Xu R, Zu L, You J and
Zhang B: MiR-517a-3p accelerates lung cancer cell proliferation and
invasion through inhibiting FOXJ3 expression. Life Sci. 108:48–53.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Challagundla KB, Pathania AS, Chava H,
Kantem NM, Dronadula VM, Coulter DW and Clarke M: FOXJ3, a novel
tumor suppressor in neuroblastoma. Mol Ther Oncol. 33:2009142025.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Huang J, Zhang Y, Zhou X, Song J, Feng Y,
Qiu T, Sheng S, Zhang M, Zhang X, Hao J, et al: Foxj3 Regulates
thermogenesis of brown and beige fat via induction of PGC-1α.
Diabetes. 73:178–196. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yuan L, Jiang N, Li Y, Wang X and Wang W:
RGS1 Enhancer RNA promotes gene transcription by recruiting
transcription factor FOXJ3 and facilitates osteoclastogenesis
through PLC-IP3R-dependent Ca2+ response in rheumatoid arthritis.
Inflammation. 48:447–463. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding Y and Chen Q: Wnt/beta-catenin
signaling pathway: An attractive potential therapeutic target in
osteosarcoma. Front Oncol. 14:14569592024. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hosseini A, Dhall A, Ikonen N, Sikora N,
Nguyen S, Shen Y, Amaral MLJ, Jiao A, Wallner F, Sergeev P, et al:
Perturbing LSD1 and WNT rewires transcription to synergistically
induce AML differentiation. Nature. 642:508–518. 2025. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Arya PN, Saranya I and Selvamurugan N:
Crosstalk between Wnt and bone morphogenetic protein signaling
during osteogenic differentiation. World J Stem Cells. 16:102–113.
2024. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Abhishek Shah A, Chand D, Ahamad S, Porwal
K, Chourasia MK, Mohanan K, Srivastava KR and Chattopadhyay N:
Therapeutic targeting of Wnt antagonists by small molecules for
treatment of osteoporosis. Biochem Pharmacol. 230:1165872024.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gong W, Li M, Zhao L, Wang P, Wang X, Wang
B, Liu X and Tu X: Sustained release of a highly specific GSK3β
inhibitor SB216763 in the PCL scaffold creates an osteogenic niche
for osteogenesis, anti-adipogenesis, and potential angiogenesis.
Front Bioeng Biotechnol. 11:12152332023. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tanthaisong P, Imsoonthornruksa S,
Ngernsoungnern A, Ngernsoungnern P, Ketudat-Cairns M and Parnpai R:
Enhanced chondrogenic differentiation of human umbilical cord
Wharton's jelly derived mesenchymal stem cells by GSK-3 inhibitors.
PLoS One. 12:e01680592017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yao J, Wu X, Qiao X, Zhang D, Zhang L, Ma
JA, Cai X, Boström KI and Yao Y: Shifting osteogenesis in vascular
calcification. JCI Insight. 6:e1430232021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Rong X, Kou Y, Zhang Y, Yang P, Tang R,
Liu H and Li M: ED-71 Prevents Glucocorticoid-induced osteoporosis
by regulating osteoblast differentiation via notch and
Wnt/β-catenin pathways. Drug Des Devel Ther. 16:3929–3946. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yang N, Zhang X, Li L, Xu T, Li M, Zhao Q,
Yu J, Wang J and Liu Z: Ginsenoside Rc promotes bone formation in
Ovariectomy-induced osteoporosis in vivo and osteogenic
differentiation in vitro. Int J Mol Sci. 23:61872022. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Abdelbaset S, Mohamed Sob MA, Mutawa G,
El-Dein MA and Abou-El-Naga AM: Therapeutic potential of different
injection methods for bone marrow mesenchymal stem cell
transplantation in Buslfan-induced male rat infertility. J Stem
Cells Regen Med. 20:26–46. 2024.PubMed/NCBI
|
|
26
|
Pajarinen J, Lin T, Gibon E, Kohno Y,
Maruyama M, Nathan K, Lu L, Yao Z and Goodman SB: Mesenchymal stem
cell-macrophage crosstalk and bone healing. Biomaterials.
196:80–89. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Sun Y, Wan B, Wang R, Zhang B, Luo P, Wang
D, Nie JJ, Chen D and Wu X: Mechanical stimulation on mesenchymal
stem cells and surrounding microenvironments in bone regeneration:
Regulations and applications. Front Cell Dev Biol. 10:8083032022.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wu Y, Xie L, Wang M, Xiong Q, Guo Y, Liang
Y, Li J, Sheng R, Deng P, Wang Y, et al: Mettl3-mediated m6A RNA
methylation regulates the fate of bone marrow mesenchymal stem
cells and osteoporosis. Nat Commun. 9:47722018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chan WCW, Tan Z, To MKT and Chan D:
Regulation and role of transcription factors in osteogenesis. Int J
Mol Sci. 22:54452021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Komori T: Regulation of skeletal
development and maintenance by Runx2 and Sp7. Int J Mol Sci.
25:101022024. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhang W, Zhang X, Li J, Zheng J, Hu X, Xu
M, Mao X and Ling J: Foxc2 and BMP2 Induce Osteogenic/odontogenic
differentiation and mineralization of human stem cells from apical
papilla. Stem Cells Int. 2018:23639172018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hong L, Sun H and Amendt BA: MicroRNA
function in craniofacial bone formation, regeneration and repair.
Bone. 144:1157892021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Jin C, Jia L, Huang Y, Zheng Y, Du N, Liu
Y and Zhou Y: Inhibition of lncRNA MIR31HG promotes osteogenic
differentiation of human Adipose-derived stem cells. Stem Cells.
34:2707–2720. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu S, Liu D, Chen C, Hamamura K,
Moshaverinia A, Yang R, Liu Y, Jin Y and Shi S: MSC Transplantation
improves osteopenia via epigenetic regulation of notch signaling in
lupus. Cell Metab. 22:606–618. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Paradise CR, Galvan ML, Kubrova E, Bowden
S, Liu E, Carstens MF, Thaler R, Stein GS, van Wijnen AJ and
Dudakovic A: The epigenetic reader Brd4 is required for osteoblast
differentiation. J Cell Physiol. 235:5293–5304. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hu L, Chen W, Qian A and Li YP:
Wnt/β-catenin signaling components and mechanisms in bone
formation, homeostasis, and disease. Bone Res. 12:392024.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Huybrechts Y, Mortier G, Boudin E and Van
Hul W: WNT signaling and bone: Lessons from skeletal dysplasias and
disorders. Front Endocrinol (Lausanne). 11:1652020. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Maeda K, Kobayashi Y, Koide M, Uehara S,
Okamoto M, Ishihara A, Kayama T, Saito M and Marumo K: The
regulation of bone metabolism and disorders by Wnt signaling. Int J
Mol Sci. 20:55252019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Wu D, Li L, Wen Z and Wang G: Romosozumab
in osteoporosis: Yesterday, today and tomorrow. J Transl Med.
21:6682023. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Alexander MS, Shi X, Voelker KA, Grange
RW, Garcia JA, Hammer RE and Garry DJ: Foxj3 transcriptionally
activates Mef2c and regulates adult skeletal muscle fiber type
identity. Dev Biol. 337:396–404. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Chen X, Wang Z, Duan N, Zhu G, Schwarz EM
and Xie C: Osteoblast-osteoclast interactions. Connect Tissue Res.
59:99–107. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Langdahl BL: Overview of treatment
approaches to osteoporosis. Br J Pharmacol. 178:1891–1906. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Khosla S and Hofbauer LC: Osteoporosis
treatment: Recent developments and ongoing challenges. Lancet
Diabetes Endocrinol. 5:898–907. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Shimizu R, Sukegawa S, Sukegawa Y,
Hasegawa K, Ono S, Nakamura T, Fujimura A, Fujisawa A, Nakano K,
Takabatake K, et al: Incidence and risk of Anti-Resorptive
Agent-related osteonecrosis of the jaw after tooth extraction: A
retrospective study. Healthcare (Basel). 10:13322022. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tong Y, Tu Y, Wang J, Liu X, Su Q, Wang Y
and Wang W: Mechanisms and therapeutic strategies linking
mesenchymal stem cells senescence to osteoporosis. Front Endocrinol
(Lausanne). 16:16258062025. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Li H and Bai L: Advances in mesenchymal
stem cell and Exosome-based therapies for aging and age-related
diseases. Stem Cell Res Ther. 16:4012025. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Liang B, Burley G, Lin S and Shi YC:
Osteoporosis pathogenesis and treatment: Existing and emerging
avenues. Cell Mol Biol Lett. 27:722022. View Article : Google Scholar : PubMed/NCBI
|
